Diabetes Health Center
Type 1 Diabetes - References
Citations
Lawson ML, Muirhead SE (2001). What is type 1 diabetes? In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 124-150. Hamilton, ON: BC Decker.
American Diabetes Association (2004). Prevention of type 1 diabetes mellitus. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S133.
American Diabetes Association (2004). Hyperglycemic crises in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S94-S102.
Hviid A, et al. (2008). Childhood vaccination and type 1 diabetes. New England Journal of Medicine, 350(14): 1398-1404.
American Diabetes Association (2004). Influenza and pneumococcal immunization in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S111-S113.
Other Works Consulted
American Diabetes Association (2006). Pancreas and islet transplantation in type 1 diabetes. Position statement. Diabetes Care, 29(4): 935.
Genuth S (2008). Type 1 diabetes mellitus. In DC Dale, DD Federman, eds., ACP Medicine, section 9, chap. 1. New York: WebMD.
Pickup J, Keen H (2002). Continuous subcutaneous insulin infusion at 25 years. Diabetes Care, 25(30): 593-598.
White SA, et al. (2001). Human islet cell transplantation: Future prospects. Diabetic Medicine, 18(2): 78-103.
WebMD Medical Reference from Healthwise
Type 1 Diabetes Topics
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Please see UROXATRAL full prescribing information.
Vinegar is in everything from coleslaw to pickles. What if you could actually use it to help prevent disease?
